In some cases, people saw a significant reduction in body weight when they took it regularly, as shown in recent clinical studies
10.1016/j.steroids.2007.02.003 8 ChanY
It varies by patient and the type of Glp-1 agonist
Although erastin and its derivatives show promising anti-tumor effects in vitro, they have not yet progressed to clinical trials
follow user journeys from diagnosis to medication and beyond through one-on-one interviews and focus groups
Katherine Saunders, an obesity medicine expert at Weill Cornell Medicine and co-founder of Intellihealth, a company providing software and clinical services for medical obesity treatment, described the approval as a "major milestone in the history of obesity medicine." When she started practicing, the most effective medications could help people lose 5% to 10% of their body weight